[The efficacy and safety of siponimod in the Russian population of patients with secondary progressive multiple sclerosis].

Evdoshenko, E P

[The efficacy and safety of siponimod in the Russian population of patients with secondary progressive multiple sclerosis]. [electronic resource] - Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova 2019 - 110-119 p. digital

Publication Type: Controlled Clinical Trial; Journal Article

1997-7298

10.17116/jnevro2019119102110 doi


Azetidines--adverse effects
Benzyl Compounds--adverse effects
Humans
Multiple Sclerosis, Chronic Progressive--drug therapy
Russia